A recent meta-analysis reveals no link between pathologic complete response and long-term survival in rectal cancer, challenging its use as a surrogate endpoint.

Neoadjuvant immunochemotherapy and sequential transoral surgery, including TORS, appears to be a feasible strategy that yields favorable oncologic and functional outcomes for patients with resectable ...

New statistical frameworks such as net treatment benefit offer a multidimensional approach to evaluating efficacy, safety, ...

A new study published in the journal of BMC Surgery showed that robotic surgery for rectal cancer exhibits oncological and ...

Total neoadjuvant therapy demonstrates consistent real-world efficacy across regimens in patients with locally advanced ...

Background: Global cancer statistics indicate colorectal cancer as the second leading cause of cancer-related deaths, with rectal cancer accounting for approximately 30% of cases. Despite neoadjuvant ...

Data are mixed on whether indocyanine green (ICG) fluorescence angiography can reduce the high rate of anastomotic leaks in patients undergoing surgery for rectal cancer. Therefore, we aimed to ...

Immunotherapy shows promise in reducing recurrence rates for high-risk skin cancer, despite mixed results in recent clinical trials.

We read with great interest the recent article by van der Schee et al in Gut .1 This study shows that endoscopic intermuscular dissection (EID) with active surveillance is safe and effective. It is a ...

Read these tips from Apartment Therapy readers for cooling off a home in the peak summer heat.

Oak Ridge researchers are converting nuclear waste into components for targeted alpha therapy, a cancer treatment that destroys cancer cells.